For pharmaceutical manufacturers and life sciences organizations, ensuring patients use medications as intended is central to outcomes, safety, and adherence. But when EHR...
10+ Years Later: Our Thoughts on Refining the EPCS IFR
By Tony Schueth, CEO & Managing Partner
ePrescribing: Progress and Opportunities
[embed]https://youtu.be/SinNiGgdJKI[/embed]
State and Federal Regulations Continue to Target the Opioid Epidemic and Part D Prescribing
By Keith Fisher, R.Ph. and Michelle Soble, R.Ph. Co-Leads, POCP Regulatory Resource Center
New NCPDP Specialty Pharmacy Workgroup to Meet on August 3
By Pooja Babbrah, Practice Lead, PBM Services
ePrescribing Impact: Medicare Part D Migration to NCPDP SCRIPT version 201701
By Michael Burger, Practice Lead, EHRs and EDI
- 1
